Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

YMAB Y-mAbs Therapeutics, Inc.

未开盘 05-16 16:00:00 EDT

11.85

-0.33

-2.71%

盘后11.85

+0.000.00%

16:02 EDT

最高12.39	最低11.74	成交量20.76万
今开12.21	昨收12.18	日振幅5.34%
总市值5.20亿	流通市值3.02亿	总股本4,388万
成交额248.32万	换手率0.81%	流通股本2,549万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"YMAB","market":"US","secType":"STK","nameCN":"Y-mAbs Therapeutics, Inc.","latestPrice":11.85,"timestamp":1715889600000,"preClose":12.18,"halted":0,"volume":207629,"hourTrading":{"tag":"盘后","latestPrice":11.85,"preClose":11.85,"latestTime":"16:02 EDT","volume":11950,"amount":141607.5,"timestamp":1715889739467},"delay":0,"floatShares":25487334,"shares":43882638,"eps":-0.496103,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.33,"latestTime":"05-16 16:00:00 EDT","open":12.21,"high":12.39,"low":11.74,"amount":2483206.60874,"amplitude":0.053366,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.496103,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715932800000},"adr":0,"listingDate":1537502400000,"adjPreClose":12.18,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":11.85,"preClose":11.85,"latestTime":"16:02 EDT","volume":11950,"amount":141607.5,"timestamp":1715889739467},"volumeRatio":0.44009},"requestUrl":"/m/hq/s/YMAB/","defaultTab":"news","newsList":[{"id":"2435545197","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435545197","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435545197?lang=zh_cn&edition=full","pubTime":"2024-05-15 00:37","pubTimestamp":1715704679,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日00时37分，Y-Mabs Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：维持Y-mAbs Therapeutics评级，由买入调整至买入评级, 目标价由21.00美元调整至22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150037597a59dc6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150037597a59dc6a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435305017","title":"HC Wainwright & Co.：维持Y-mAbs Therapeutics(YMAB.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435305017","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435305017?lang=zh_cn&edition=full","pubTime":"2024-05-14 01:55","pubTimestamp":1715622904,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Y-mAbs Therapeutics(YMAB.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140155078b02cd39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140155078b02cd39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435370229","title":"Y-Mabs Therapeutics, Inc.2024财年第一财季实现净利润-6.63百万美元，同比减少3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435370229","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435370229?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:24","pubTimestamp":1715617469,"startTime":"0","endTime":"0","summary":"3月31日，Y-Mabs Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-6.63百万美元，同比减少3.76%；其中营业收入为19.93百万美元，同比减少1.58%，每股基本收益为-0.15美元。从资产负债表来看，Y-Mabs Therapeutics, Inc.总负债24.13百万美元，其中短期债务888000.00美元，资产负债比为0.06，流动比率为0.07。机构评级：截至2024年3月31日，当前有7家机构对Y-Mabs Therapeutics, Inc.目标价做出预测，其中目标均价为21.14美元，其中最低目标价为12.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400244087632623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400244087632623&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434854477","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854477","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434854477?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:41","pubTimestamp":1715348485,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时41分，Y-Mabs Therapeutics, Inc.股票出现异动，股价急速下挫5.01%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Macrogenics, Inc.较为活跃，换手率分别为46.09%、22.16%、8.09%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、诺瓦瓦克斯医药、Coherus Biosciences, Inc.，振幅分别为31.88%、31.54%、15.01%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102141257a594105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102141257a594105&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434018506","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434018506","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434018506?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:40","pubTimestamp":1715262012,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时40分，Y-Mabs Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、再鼎医药、Notable Labs, Ltd.涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃，换手率分别为41.60%、15.82%、4.35%，振幅较大的相关个股有Notable Labs, Ltd.、180 Life Sciences Corp C/Wts 07/11/2025、Alzamend Neuro, Inc.，振幅分别为27.83%、21.74%、13.26%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509214012861ec1b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509214012861ec1b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433218377","title":"Y-Mabs Therapeutics, Inc.盘中异动 股价大跌14.86%报14.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433218377","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433218377?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175066,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速下跌14.86%。截至发稿，该股报14.65美元/股，成交量1.4193万股，换手率0.03%，振幅5.29%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Repare Therapeutics Inc.、Cel-Sci Corporation、内克塔治疗涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为198.20%、24.67%、10.06%，振幅较大的相关个股有Veru Inc.、Rani Therapeutics Holdings, Inc.、Transcode Therapeutics, Inc.，振幅分别为9.20%、8.58%、6.03%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821310687e095af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821310687e095af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432315503","title":"Y-mAbs Therapeutics Inc   预计每股亏损14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432315503","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432315503?lang=zh_cn&edition=full","pubTime":"2024-05-04 06:35","pubTimestamp":1714775700,"startTime":"0","endTime":"0","summary":"   * Y-mAbs Therapeutics Inc    将于5月7日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* LSEG分析师对Y-mAbs Therapeutics Inc的平均预期是每股亏损14美分。* 华尔街对 Y-mAbs Therapeutics Inc 的 12 个月目标价中位数为 22.00 美元，高于其上次收盘价 17.25 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429116801","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.28%报15.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429116801","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429116801?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:37","pubTimestamp":1713883027,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时37分，Y-Mabs Therapeutics, Inc.股票出现异动，股价急速上涨5.28%。截至发稿，该股报15.96美元/股，成交量18.4803万股，换手率0.42%，振幅6.56%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223707861e8346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223707861e8346&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426221497","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426221497","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426221497?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:53","pubTimestamp":1712757239,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时53分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。截至发稿，该股报13.36美元/股，成交量1.9733万股，换手率0.05%，振幅2.84%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1374.17%、71.03%、28.67%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为62.83%、31.96%、24.26%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102153597a51e8da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102153597a51e8da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424822797","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424822797","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424822797?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:08","pubTimestamp":1712164091,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时08分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速下跌5.25%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为531.72%、490.32%、76.72%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进，振幅分别为97.51%、58.48%、44.44%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401081187e7dfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401081187e7dfc0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422955928","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.10%报16.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422955928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422955928?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:42","pubTimestamp":1711568527,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时42分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报16.50美元/股，成交量10.2447万股，换手率0.23%，振幅7.17%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Ibio, Inc.、Nutriband Inc C/Wts 、Moolec Science Sa C/Wts 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为4682.81%、1351.03%、89.25%，振幅较大的相关个股有Ibio, Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为150.43%、80.26%、78.00%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803420787e7c5cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803420787e7c5cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421991046","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421991046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421991046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:30","pubTimestamp":1711027849,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时30分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速拉升5.29%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Argenx Se、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Kazia Therapeutics Limited较为活跃，换手率分别为63.61%、13.81%、7.93%，振幅较大的相关个股有Immatics N.V.、Virpax Pharmaceuticals, Inc.、Context Therapeutics Inc.，振幅分别为7.03%、6.84%、6.08%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213050861e0166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213050861e0166&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419833819","title":"BUZZ-首席财务官下台后，Y-mAbs Therapeutics 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2419833819","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419833819?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:36","pubTimestamp":1710426963,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月14日 - ** 制药公司Y-mAbs Therapeutics   股价下跌6%，至14.88美元 ** 公司宣布自2015年4月成立以来一直担任首席财务官的Bo Kruse辞职** YMAB已开始寻找继任者 ** 克鲁泽将继续担任首席财务官，直至继任者确定 - YMAB** 包括盘中走势在内，该股在过去12个月中上涨了一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607977","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报14.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607977","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607977?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:49","pubTimestamp":1710424162,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时49分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅跳水5.78%。截至发稿，该股报14.93美元/股，成交量2.494万股，换手率0.06%，振幅2.40%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214922791a7c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214922791a7c6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418363628","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅跳水5.62%报16.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418363628","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418363628?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:41","pubTimestamp":1710164510,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时41分，Y-Mabs Therapeutics, Inc.股票出现异动，股价大幅下挫5.62%。截至发稿，该股报16.63美元/股，成交量9607股，换手率0.02%，振幅2.61%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112141507a4b93da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112141507a4b93da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418342061","title":"Y-Mabs Therapeutics, Inc.2023财年实现净利润-21.43百万美元，同比增加77.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418342061","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418342061?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:18","pubTimestamp":1709914682,"startTime":"0","endTime":"0","summary":"12月31日，Y-Mabs Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-21.43百万美元，同比增加77.58%；其中营业收入为84.82百万美元，同比增加29.95%，每股基本收益为-0.49美元。从资产负债表来看，Y-Mabs Therapeutics, Inc.总负债26.88百万美元，其中短期债务902000.00美元，资产负债比为0.05，流动比率为0.06。机构评级：截至2023年12月31日，当前有7家机构对Y-Mabs Therapeutics, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为10.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030900180487662619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030900180487662619&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417592421","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报16.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417592421","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417592421?lang=zh_cn&edition=full","pubTime":"2024-03-06 04:01","pubTimestamp":1709668917,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日04时01分，Y-Mabs Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报16.46美元/股，成交量13.9331万股，换手率0.32%，振幅4.73%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.53%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604015779178e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604015779178e95&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ymabs.com","stockEarnings":[{"period":"1week","weight":-0.0793},{"period":"1month","weight":-0.2173},{"period":"3month","weight":-0.2726},{"period":"6month","weight":1.1823},{"period":"1year","weight":0.2421},{"period":"ytd","weight":0.7375}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Y-mAbs Therapeutics, Inc.于2015年4月30日根据特拉华州法律注册成立。该公司是一家后期临床生物制药公司，专注于开发和将用于治疗癌症的新型抗体治疗产品商业化。YY-mAbs Therapeutics, Inc.拥有广泛而先进的产品系列，包括两个关键阶段产品候选物 - 纳西他马和omburtamab-分别针对与GD2和B7-H3相关的肿瘤。该公司正在开发用于治疗患有复发或难治性或R / R，高风险神经母细胞瘤或NB的儿科患者的naxitamab，以及用于治疗患有中枢神经系统或中枢神经系统，软脑膜转移瘤或LM的儿科患者的放射性标记的omburtamab来自NB。NB是在交感神经系统中发展的罕见且几乎完全是小儿的癌症，并且CNS / LM是NB的罕见且通常致命的并发症，其中疾病传播到CNS中的脑膜和脊髓周围的脑膜或脑膜。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053593},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.024313},{"month":3,"riseRate":0.5,"avgChangeRate":0.092289},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.000439},{"month":5,"riseRate":0.666667,"avgChangeRate":0.138455},{"month":6,"riseRate":0.6,"avgChangeRate":0.049794},{"month":7,"riseRate":0.2,"avgChangeRate":-0.060414},{"month":8,"riseRate":0.6,"avgChangeRate":0.041296},{"month":9,"riseRate":0.2,"avgChangeRate":-0.045617},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.11266},{"month":11,"riseRate":0.833333,"avgChangeRate":0.064156},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024264}],"exchange":"NASDAQ","name":"Y-mAbs Therapeutics, Inc.","nameEN":"Y-mAbs Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Y-mAbs Therapeutics, Inc.,YMAB,Y-mAbs Therapeutics, Inc.股票,Y-mAbs Therapeutics, Inc.股票老虎,Y-mAbs Therapeutics, Inc.股票老虎国际,Y-mAbs Therapeutics, Inc.行情,Y-mAbs Therapeutics, Inc.股票行情,Y-mAbs Therapeutics, Inc.股价,Y-mAbs Therapeutics, Inc.股市,Y-mAbs Therapeutics, Inc.股票价格,Y-mAbs Therapeutics, Inc.股票交易,Y-mAbs Therapeutics, Inc.股票购买,Y-mAbs Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}